GSE115384 CELSR2 knockdown 5 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE115384_CELSR2 knockdown_5_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE115384_CELSR2 knockdown_5_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE115384_CELSR2 knockdown_5_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE115384_CELSR2 knockdown_5_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

CASTOR family member 3, pseudogene

Gene

H3 clustered histone 6

Gene

pleckstrin homology and RUN domain containing M1 pseudogene 1

Gene

WASP family homolog 5, pseudogene

Gene

STARD4 antisense RNA 1

Gene

GOLGA2 pseudogene 5

Gene

STAG3 cohesin complex component like 5, pseudogene

Gene

negative regulator of antiviral response

Gene

ZNF528 antisense RNA 1

Gene

TRG antisense RNA 1

  • Gene

    CASTOR family member 3, pseudogene


  • Gene

    H3 clustered histone 6


  • Gene

    pleckstrin homology and RUN domain containing M1 pseudogene 1


  • Gene

    WASP family homolog 5, pseudogene


  • Gene

    STARD4 antisense RNA 1


  • Gene

    GOLGA2 pseudogene 5


  • Gene

    STAG3 cohesin complex component like 5, pseudogene


  • Gene

    negative regulator of antiviral response


  • Gene

    ZNF528 antisense RNA 1


  • Gene

    TRG antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.